| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |